2730. Clinically significant cytomegalovirus infection in patients with lymphoma and no prior cellular therapy

BACKGROUND: Reactivation of cytomegalovirus (CMV) is commonly reported in lymphoma patients who undergo cellular therapy, with often poor outcomes. The risk for CMV reactivation in patients with lymphoma prior to cellular therapy is not well understood. As new alternative immunosuppressive therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Zubovskaia, Anna, Khawaja, Fareed, Chemaly, Roy F, Primeaux, Brian, Waleed, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679170/
http://dx.doi.org/10.1093/ofid/ofad500.2341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679170/
http://dx.doi.org/10.1093/ofid/ofad500.2341

Ejemplares similares